绿竹生物于2001年11月成立,公司秉承以人为本,精益求精的宗旨,以人用疫苗、治疗性双功能抗体药物为主要研究方向,坚持自主研发为主,同时积极引进国际领先的技术,研发及生产以满足临床需求的、主要用于疾病防控、疾病治疗的多种疫苗制品及治疗用生物制品。
Luzhu Biotechnology was found in November 2001. The company adheres to the development idea of “Seeking perfection for people”, focus on human vaccine research and therapeutic bispecific antibody development, insists on independent research and development and also strategically introduces leading international technologies to develop and produce various vaccine products and therapeutic biological products that meet clinical needs for disease prevention, control and treatment.
绿竹生物致力于新型生物抗体和疫苗研究开发,为能为社会不断地提供质优价廉的药品和疫苗目标而奋斗。
Luzhu Biotech is devoted to the R&D of novel antibodies and vaccines, and strive for the goal of providing high-quality and affordable drugs and vaccines for the society.
绿竹生物拥有一个符合GMP要求的中试车间(北京),两个生产基地。
Luzhu Biotech has a pilot and scale-up workshop meeting GMP requirements in Beijing and two production bases.
Industry
Biotechnology, Chemotherapeutic preparations, Health, medical and pharmaceutical, Chemicals, Pharmaceuticals & Plastics, Antibodies, monoclonal and polyclonal, Chemicals for laboratories and microbiology, Chemical products, Reagents for chemical medical analyses
HQ Location
北京市通州区工业开发区广通街3号
北京市, 北京市 101113, CN
Keywords
带状疱疹疫苗重组疫苗双抗药物创新药物and 抗体药物